Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | DRD4 | P21917 | 2/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6767435 | 1.00 | ALDH1A1 (0.51) | ALDH1A1TSHRDRD4DRD2SMN1; SMN2 | |
| SCHEMBL6766256 | 0.89 | DRD4 (0.55) | ALDH1A1TSHRDRD4DRD2POLB | |
| SCHEMBL6766251 | 0.89 | DRD4 (0.55) | ALDH1A1TSHRDRD4DRD2POLB | |
| SCHEMBL6770494 | 0.85 | ALDH1A1 (0.55) | ALDH1A1TSHRSMN1; SMN2HTTPOLB | |
| SCHEMBL6770492 | 0.85 | ALDH1A1 (0.55) | ALDH1A1TSHRSMN1; SMN2HTTPOLB | |
| SCHEMBL6770251 | 0.84 | ALDH1A1 (0.47) | ALDH1A1TSHRSMN1; SMN2HTTPOLB | |
| SCHEMBL6770252 | 0.84 | ALDH1A1 (0.47) | ALDH1A1TSHRSMN1; SMN2HTTPOLB | |
| SCHEMBL6766324 | 0.80 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2HTTLMNA | |
| SCHEMBL6766329 | 0.80 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2HTTLMNA | |
| SCHEMBL6771215 | 0.79 | ALDH1A1 (0.61) | ALDH1A1TSHRSMN1; SMN2HTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6716857-B2 | 1-(3-HYDROCARBYLOXYIMINO-3-(1-ALKYL-1,2,5,6-TETRAHYDROPYRID-3-YL) -ALKYLPYRROLIDIN-2-ONE DERIVATIVES; RECEPTIVITY; ANALGESICS, GLAUCOMA, PSYCHOSIS, SCHIZOPHRENIA, ANXIOLYTIC AGENTS, BIPOLAR DISORDERS; ANTIDEPRESSANTS; SLEEP DISORDERS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-04-06 | — | — | US | claimed |
| US-20030119880-A1 | Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-06-26 | — | — | US | claimed |
| US-6716857-B2 | 1-(3-HYDROCARBYLOXYIMINO-3-(1-ALKYL-1,2,5,6-TETRAHYDROPYRID-3-YL) -ALKYLPYRROLIDIN-2-ONE DERIVATIVES; RECEPTIVITY; ANALGESICS, GLAUCOMA, PSYCHOSIS, SCHIZOPHRENIA, ANXIOLYTIC AGENTS, BIPOLAR DISORDERS; ANTIDEPRESSANTS; SLEEP DISORDERS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-04-06 | — | — | US | disclosed |
| US-20030119880-A1 | Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030119880-A1 | Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors | CHRM1, CHRM3, CHRM2 | ALDH1A1 596/4885TSHR 92/4885DRD4 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.